Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-06

Clinical Trial Update: Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal [NA]

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating efavirenz plus lamivudine/zidovudine in treatment-naive HIV-infected adults in Senegal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)
  • Lamivudine/Zidovudine (lamivudine; zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED